JP2017531678A5 - - Google Patents

Download PDF

Info

Publication number
JP2017531678A5
JP2017531678A5 JP2017522086A JP2017522086A JP2017531678A5 JP 2017531678 A5 JP2017531678 A5 JP 2017531678A5 JP 2017522086 A JP2017522086 A JP 2017522086A JP 2017522086 A JP2017522086 A JP 2017522086A JP 2017531678 A5 JP2017531678 A5 JP 2017531678A5
Authority
JP
Japan
Prior art keywords
group
alkyl
substituted
groups
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017522086A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017531678A (ja
JP6616412B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/074431 external-priority patent/WO2016062790A1/en
Publication of JP2017531678A publication Critical patent/JP2017531678A/ja
Publication of JP2017531678A5 publication Critical patent/JP2017531678A5/ja
Application granted granted Critical
Publication of JP6616412B2 publication Critical patent/JP6616412B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017522086A 2014-10-23 2015-10-22 Nik阻害剤としての新規のピラゾロピリミジン誘導体 Expired - Fee Related JP6616412B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14190073 2014-10-23
EP14190073.8 2014-10-23
PCT/EP2015/074431 WO2016062790A1 (en) 2014-10-23 2015-10-22 New pyrazolopyrimidine derivatives as nik inhibitors

Publications (3)

Publication Number Publication Date
JP2017531678A JP2017531678A (ja) 2017-10-26
JP2017531678A5 true JP2017531678A5 (cg-RX-API-DMAC7.html) 2019-11-21
JP6616412B2 JP6616412B2 (ja) 2019-12-04

Family

ID=51846471

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017522086A Expired - Fee Related JP6616412B2 (ja) 2014-10-23 2015-10-22 Nik阻害剤としての新規のピラゾロピリミジン誘導体

Country Status (13)

Country Link
US (2) US10221180B2 (cg-RX-API-DMAC7.html)
EP (1) EP3209663B1 (cg-RX-API-DMAC7.html)
JP (1) JP6616412B2 (cg-RX-API-DMAC7.html)
KR (1) KR102523405B1 (cg-RX-API-DMAC7.html)
CN (1) CN107074882B (cg-RX-API-DMAC7.html)
AU (1) AU2015334915B2 (cg-RX-API-DMAC7.html)
BR (1) BR112017007704B1 (cg-RX-API-DMAC7.html)
CA (1) CA2960574C (cg-RX-API-DMAC7.html)
EA (1) EA033237B1 (cg-RX-API-DMAC7.html)
ES (1) ES2715104T3 (cg-RX-API-DMAC7.html)
IL (1) IL251778B (cg-RX-API-DMAC7.html)
MX (1) MX371152B (cg-RX-API-DMAC7.html)
WO (1) WO2016062790A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI663166B (zh) 2013-04-24 2019-06-21 健生藥品公司 新化合物
TWI704146B (zh) 2013-09-26 2020-09-11 比利時商健生藥品公司 用作NIK抑制劑之新的1-(4-嘧啶基)-1H-吡唑並[3,2-c]吡啶衍生物
TWI627173B (zh) 2013-09-26 2018-06-21 比利時商健生藥品公司 作為NIK抑制劑的新穎3-(1H-吡唑-4-基)-1H-吡咯并[2,3-c]吡啶衍生物
EA033237B1 (ru) 2014-10-23 2019-09-30 Янссен Фармацевтика Нв Новые производные пиразолопиримидина в качестве ингибиторов nik, фармацевтическая композиция и лекарственное средство, содержащее ее
KR102524622B1 (ko) 2014-10-23 2023-04-20 얀센 파마슈티카 엔.브이. Nik 억제제로서의 신규 티에노피리미딘 유도체
ES2718557T3 (es) 2014-10-23 2019-07-02 Janssen Pharmaceutica Nv Nuevos compuestos como inhibidores de nik
EP3209654B1 (en) 2014-10-23 2018-10-03 Janssen Pharmaceutica N.V. New pyrazole derivatives as nik inhibitors
EP3801499B1 (en) 2018-06-07 2024-02-28 Disarm Therapeutics, Inc. Inhibitors of sarm1
WO2019243965A1 (en) * 2018-06-18 2019-12-26 Janssen Pharmaceutica Nv Pyrazole derivatives as malt1 inhibitors
EP3897670A4 (en) 2018-12-19 2022-09-07 Disarm Therapeutics, Inc. MRSA1 INHIBITORS IN COMBINATION WITH NEUROPROTECTIVE AGENTS
US20220162206A1 (en) * 2019-03-29 2022-05-26 Kowa Company, Ltd. Novel azaindole derivative
FI3976597T3 (fi) 2019-05-31 2024-09-25 Janssen Pharmaceutica Nv Nf-kb:tä indusoivan kinaasin pienimolekyylisiä estäjiä

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990007926A1 (en) * 1989-01-20 1990-07-26 Pfizer Inc. 3-(1,2,5,6-tetrahydropyridyl)-pyrrolopyridines
MXPA06012449A (es) 2004-04-26 2007-01-17 Pfizer Inhibidores de la enzima integrasa de vih.
TW200736260A (en) 2005-11-10 2007-10-01 Smithkline Beecham Corp Inhibitors of Akt activity
DE102008005493A1 (de) 2008-01-22 2009-07-23 Merck Patent Gmbh 4-(Pyrrolo[2,3-c] pyridine-3-yl)-pyrimidin-2-yl-amin-derivate
US20110086834A1 (en) 2008-06-26 2011-04-14 Amgen Inc. Alkynyl alcohols as kinase inhibitors
EP2320895A2 (en) 2008-07-03 2011-05-18 Exelixis, Inc. Cdk modulators
US20110183975A1 (en) 2008-10-07 2011-07-28 Yasuhiro Goto Novel 6-azaindole aminopyrimidine derivatives having nik inhibitory activity
CN101723936B (zh) 2008-10-27 2014-01-15 上海睿星基因技术有限公司 激酶抑制剂及其在药学中的用途
WO2011050245A1 (en) 2009-10-23 2011-04-28 Yangbo Feng Bicyclic heteroaryls as kinase inhibitors
KR20130133051A (ko) 2011-03-16 2013-12-05 에프. 호프만-라 로슈 아게 6,5-헤테로사이클릭 프로파길릭 알콜 화합물 및 이의 용도
TWI663166B (zh) 2013-04-24 2019-06-21 健生藥品公司 新化合物
TWI704146B (zh) 2013-09-26 2020-09-11 比利時商健生藥品公司 用作NIK抑制劑之新的1-(4-嘧啶基)-1H-吡唑並[3,2-c]吡啶衍生物
TWI627173B (zh) 2013-09-26 2018-06-21 比利時商健生藥品公司 作為NIK抑制劑的新穎3-(1H-吡唑-4-基)-1H-吡咯并[2,3-c]吡啶衍生物
ES2718557T3 (es) 2014-10-23 2019-07-02 Janssen Pharmaceutica Nv Nuevos compuestos como inhibidores de nik
EA033237B1 (ru) 2014-10-23 2019-09-30 Янссен Фармацевтика Нв Новые производные пиразолопиримидина в качестве ингибиторов nik, фармацевтическая композиция и лекарственное средство, содержащее ее
KR102524622B1 (ko) * 2014-10-23 2023-04-20 얀센 파마슈티카 엔.브이. Nik 억제제로서의 신규 티에노피리미딘 유도체
EP3209654B1 (en) 2014-10-23 2018-10-03 Janssen Pharmaceutica N.V. New pyrazole derivatives as nik inhibitors

Similar Documents

Publication Publication Date Title
JP2017531678A5 (cg-RX-API-DMAC7.html)
JP2017531677A5 (cg-RX-API-DMAC7.html)
AU2014233414B2 (en) N-acyl-N'-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities
JP2016531868A5 (cg-RX-API-DMAC7.html)
JP2019094345A5 (cg-RX-API-DMAC7.html)
US20170157134A1 (en) Combination therapy
JP2019524883A5 (cg-RX-API-DMAC7.html)
JP2020169187A (ja) 僧帽弁疾患による無症候性心不全の患者の心臓サイズの減少及び/又は臨床的症候の発生の遅延のためのピモベンダンの使用
JP2016537366A5 (cg-RX-API-DMAC7.html)
JP2014037426A5 (cg-RX-API-DMAC7.html)
JP2012510458A5 (cg-RX-API-DMAC7.html)
JP2015503540A5 (cg-RX-API-DMAC7.html)
MX2010007374A (es) Nuevos derivados de c-21-ceto lupano, preparacion y uso de los mismos.
JP2019515884A5 (cg-RX-API-DMAC7.html)
JP2014506582A5 (cg-RX-API-DMAC7.html)
RU2018113718A (ru) Новые соединения
JP2019505529A5 (cg-RX-API-DMAC7.html)
JP2019535723A5 (cg-RX-API-DMAC7.html)
RU2012130929A (ru) Гетероциклические соединения в качестве ингибиторов янус-киназы
JP2024507414A (ja) ウイルス感染症治療のためのrock2阻害剤
RU2007103831A (ru) Производные пиразола
CN110461855A (zh) 氮杂环丁烷衍生物
MX2010013978A (es) Derivados de 5-(4-metanosulfonilfenil)tiazol para el tratamiento de enfermedades inflamatorias agudas y cronicas.
JP2015524835A5 (cg-RX-API-DMAC7.html)
JP2015534985A5 (cg-RX-API-DMAC7.html)